Pharma stock down 28% in 2022. Brokerage gives 'Buy' tag as 'stock attractive'
PhillipCapital has recommended its Buy on Biocon shares with revised target price29-12-2022
29-12-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meeting conducted with Institutional Investors/Research Analysts.23-12-2022
Mehul Kothari recommends Biocon, Aurobindo Pharma for trading gains
According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.23-12-2022
BIOCON LTD. - 532523 - Notification To Stock Exchange
'Biocon Limited has been issued a Good Manufacturing Practice (GMP) Certificate of Compliance by the European Directorate for the Quality of Medicines & HealthCare (EDQM), for our Active Pharmaceutical Ingredient (API) manufacturing facility in Bangalore. This certification is based on a GMP inspection of the site that was conducted between the 12th and 14th of September 2022.' The above information will also be available on the website of the Company at www.biocon.com.22-12-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed the press release titled 'Biocon Biologics Recognized as a Company with Great Managers; Two Managers conferred with individual 'Great Managers Award 2022' '. The above information will also be available on the website of the Company at www.biocon.com.22-12-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meeting conducted with Institutional Investors/Research Analysts.22-12-2022
Trade Spotlight | What should you do with Glenmark Pharma, Biocon, LTIMindtree on Thursday?
Biocon shares gained 3.5 percent at Rs 271 and formed long bullish candle on the daily charts with robust volumes. Also there was Morning Star kind of pattern formation, which is generally called as a bullish reversal pattern formed in an downtrend.22-12-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Further to our letter dated December 20, 2022 regarding intimation of Postal Ballot Notice, and in compliance with the provisions of Regulation 30 and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, please find enclosed copies of newspaper advertisement published in Financial Express (English Language - All India Edition) and Vijayavani, (Kannada Language - Bengaluru Edition) on December 21, 2022 with regard to Postal Ballot Notice and Remote e-voting. The above information will also be available on the website of the Company at www.biocon.com.21-12-2022
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Meeting conducted with Institutional Investors/Research Analysts.21-12-2022
BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith a copy of Notice of Postal Ballot dated December 19, 2022, seeking approval of the members for the various matters as mentioned in the enclosed Postal ballot notice.20-12-2022